BehaVR CEO weighs in on potential $140M development deal

The company, founded by former Humana exec Aaron Gani in 2016, just inked a deal to develop and commercialize prescription digital therapeutics for treatment of social anxiety, generalized anxiety and major depressive disorders.

Source: bizjournals.com Health Care:Biotechnology headlines - October 20, 2021 Category: Biotechnology Authors: Haley Cawthon Source Type: news